Mariman and Hamel' report that in families where two offspring are affected with neural tube defects (NTD) there are more same sex affected pairs than opposite sex affected pairs. A number of points arise.
(1) The null hypothesis (as expressed by binomial expectation) is not that there should be exact equality because the sex ratio (proportion male) of cases is not exactly 0 5.
(2) Since the sex ratios of spina bifidas in general exceed those of anencephalics,"3 one would expect concordance for sex in affected NTD sib pairs if the defects, to some extent 'breed true'. There is evidence for such a suggestion," though the point has been disputed.' Account has been taken of such a possibility by disaggregating the data into sib pairs of anencephalics, sib pairs of spina bifidas, and pairs comprising one of each.7 In that paper, data were pooled from a number of sources, and the table here reproduces those pooled data. None of these three individual distributions, nor (more important) their components treated separately, nor their overall total, shows a significant departure from binomial expectation.
The combinations of the sexes of cases of neural tube defect in sibships in which exactly two are affected (by the nature of the defects) (reproduced from James7). Areas outside my specific field of competence or interest were grafts of haemopoietic and immunogenic tissue, gonads, and comeas. However, the chapter on clinical results of transplanting human fetal pancreas was depressingly familiar and familiarly depressing. Thus, from over 100 human fetal nigral cell grafts in parkinsonians, there is conclusive evidence of success in only four; some others may well have been successful, but definite proof is lacking. Similarly, despite 1582 human fetal pancreatic grafts for diabetes up to June 1990 and "numerous claims of graft functions", in only four patients has graft survival been shown, and in none of these is there conclusive evidence of graft functioning. Excellent basic and preclinical work in this field so often seems to fall at the last hurdle with clinicians who can operate with great skill but inadequately understand the disease they are experimenting upon, and hence lack the means to show whether the procedure itself has been effective. I have heard one such pioneer claim that because of information overload from his vast and inconclusive series, fewer data should be collected from each subject. On the contrary, rather like Aesop's tortoise, I tend to feel that the opposite approach (meticulous controlled monitoring of a few carefully studied subjects) has more to offer. If this message is beginning to trickle through, then perhaps the recent temporary moratorium on NIH funding for human fetal grafts in the USA may actually have been no bad thing. Human molecular genetics is one of the most rapidly developing fields within the biological sciences and this coupled with its widespread importance for clinical practice means that many scientists and clinicians need an introduction to this subject. The first edition of Molecular Basis of Inherited Disease was very successful in this role and the second edition is an admirable successor. A second edition was essential to include new developments over the past four years, for example, interphase FISH, mutational screening approaches, unstable length mutations, genomic imprinting, and gene therapy.
Four sections cover the types of genetic markers, methods for locating genes (for single gene disorders), gene cloning strategies, and the molecular pathology of a variety of the commoner single gene disorders. A basic knowledge of DNA and the basic principles of genetics is assumed (as would be covered in school biology) but otherwise techniques and concepts are clearly explained with concise text and bicolour diagrams. References to original work and for further reading are included, as are two glossaries for technical and medical terms.
The present emphasis is rightly on the mapping and cloning of genes for the single gene disorders and I suspect that future editions will want to place more emphasis on approaches to the analysis of multifactorial disorders, to gene therapy, and to transgenic studies for elucidation of pathophysiology. Minor criticisms are the use of unusual sym-
